nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—Sulfadiazine—malaria	0.0866	0.107	CbGbCtD
Ethosuximide—CYP2E1—Proguanil—malaria	0.0692	0.0859	CbGbCtD
Ethosuximide—CYP3A5—Artemether—malaria	0.0572	0.071	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Quinine—malaria	0.0462	0.0573	CbGbCtD
Ethosuximide—CYP3A7—Quinine—malaria	0.0462	0.0573	CbGbCtD
Ethosuximide—CYP3A4—Clindamycin—malaria	0.0457	0.0567	CbGbCtD
Ethosuximide—CYP2E1—Quinine—malaria	0.0446	0.0554	CbGbCtD
Ethosuximide—CYP3A7—Quinidine—malaria	0.0406	0.0504	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Quinidine—malaria	0.0406	0.0504	CbGbCtD
Ethosuximide—CYP2E1—Quinidine—malaria	0.0392	0.0486	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Dapsone—malaria	0.035	0.0435	CbGbCtD
Ethosuximide—CYP3A7—Dapsone—malaria	0.035	0.0435	CbGbCtD
Ethosuximide—CYP3A5—Quinine—malaria	0.0347	0.043	CbGbCtD
Ethosuximide—CYP2E1—Dapsone—malaria	0.0338	0.042	CbGbCtD
Ethosuximide—CYP3A5—Dapsone—malaria	0.0263	0.0326	CbGbCtD
Ethosuximide—CYP3A4—Sulfadiazine—malaria	0.0262	0.0326	CbGbCtD
Ethosuximide—CYP3A4—Artemether—malaria	0.0223	0.0277	CbGbCtD
Ethosuximide—CYP3A4—Proguanil—malaria	0.021	0.026	CbGbCtD
Ethosuximide—CYP3A4—Doxycycline—malaria	0.0199	0.0247	CbGbCtD
Ethosuximide—CYP3A4—Quinine—malaria	0.0135	0.0168	CbGbCtD
Ethosuximide—CYP3A4—Quinidine—malaria	0.0119	0.0147	CbGbCtD
Ethosuximide—CYP3A4—Dapsone—malaria	0.0102	0.0127	CbGbCtD
Ethosuximide—Systemic lupus erythematosus—Sulfadiazine—malaria	0.00361	0.0207	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Quinine—malaria	0.00263	0.0151	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Quinidine—malaria	0.00263	0.0151	CcSEcCtD
Ethosuximide—Gastrointestinal symptom NOS—Clindamycin—malaria	0.00253	0.0145	CcSEcCtD
Ethosuximide—CYP3A43—liver—malaria	0.00253	0.128	CbGeAlD
Ethosuximide—Gastrointestinal symptom NOS—Quinine—malaria	0.00248	0.0142	CcSEcCtD
Ethosuximide—Gastrointestinal symptom NOS—Quinidine—malaria	0.00248	0.0142	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Quinidine barbiturate—malaria	0.00238	0.0136	CcSEcCtD
Ethosuximide—Drug eruption—Quinine—malaria	0.00237	0.0136	CcSEcCtD
Ethosuximide—Drug eruption—Quinidine—malaria	0.00237	0.0136	CcSEcCtD
Ethosuximide—Pancytopenia—Pyrimethamine—malaria	0.0023	0.0132	CcSEcCtD
Ethosuximide—Gastrointestinal symptom NOS—Quinidine barbiturate—malaria	0.00224	0.0128	CcSEcCtD
Ethosuximide—CACNA1G—digestive system—malaria	0.00219	0.11	CbGeAlD
Ethosuximide—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00214	0.0123	CcSEcCtD
Ethosuximide—Drug eruption—Quinidine barbiturate—malaria	0.00214	0.0123	CcSEcCtD
Ethosuximide—Haematuria—Pyrimethamine—malaria	0.00206	0.0118	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Clindamycin—malaria	0.00201	0.0115	CcSEcCtD
Ethosuximide—Rash erythematous—Clindamycin—malaria	0.00194	0.0111	CcSEcCtD
Ethosuximide—Suicidal ideation—Quinidine barbiturate—malaria	0.00188	0.0108	CcSEcCtD
Ethosuximide—Aplastic anaemia—Sulfadiazine—malaria	0.00187	0.0107	CcSEcCtD
Ethosuximide—Erythema multiforme—Pyrimethamine—malaria	0.00183	0.0105	CcSEcCtD
Ethosuximide—Pancytopenia—Proguanil—malaria	0.00179	0.0103	CcSEcCtD
Ethosuximide—Leukopenia—Pyrimethamine—malaria	0.00151	0.00865	CcSEcCtD
Ethosuximide—CYP3A5—blood plasma—malaria	0.00139	0.0705	CbGeAlD
Ethosuximide—Aplastic anaemia—Quinine—malaria	0.00137	0.00784	CcSEcCtD
Ethosuximide—Aplastic anaemia—Quinidine—malaria	0.00137	0.00784	CcSEcCtD
Ethosuximide—Immune system disorder—Proguanil—malaria	0.00136	0.00782	CcSEcCtD
Ethosuximide—Ataxia—Sulfadiazine—malaria	0.00136	0.00781	CcSEcCtD
Ethosuximide—Mediastinal disorder—Proguanil—malaria	0.00136	0.0078	CcSEcCtD
Ethosuximide—Mental disorder—Proguanil—malaria	0.00132	0.00758	CcSEcCtD
Ethosuximide—Malnutrition—Proguanil—malaria	0.00131	0.00753	CcSEcCtD
Ethosuximide—Anorexia—Pyrimethamine—malaria	0.00131	0.00752	CcSEcCtD
Ethosuximide—CYP2E1—blood plasma—malaria	0.0013	0.0657	CbGeAlD
Ethosuximide—CACNA1G—brain—malaria	0.00129	0.0653	CbGeAlD
Ethosuximide—Aplastic anaemia—Quinidine barbiturate—malaria	0.00124	0.00708	CcSEcCtD
Ethosuximide—Aplastic anaemia—Pentoxifylline—malaria	0.00123	0.00707	CcSEcCtD
Ethosuximide—Decreased appetite—Pyrimethamine—malaria	0.0012	0.00686	CcSEcCtD
Ethosuximide—Hyperkinesia—Quinidine barbiturate—malaria	0.00115	0.00658	CcSEcCtD
Ethosuximide—Mental disability—Quinidine barbiturate—malaria	0.00114	0.00654	CcSEcCtD
Ethosuximide—CYP3A7—liver—malaria	0.00113	0.0574	CbGeAlD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00111	0.00637	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00111	0.00634	CcSEcCtD
Ethosuximide—Sleep disorder—Pentoxifylline—malaria	0.0011	0.00631	CcSEcCtD
Ethosuximide—Psychotic disorder—Dapsone—malaria	0.00109	0.00624	CcSEcCtD
Ethosuximide—Nervous system disorder—Proguanil—malaria	0.00105	0.00603	CcSEcCtD
Ethosuximide—CYP3A4—blood plasma—malaria	0.00105	0.0529	CbGeAlD
Ethosuximide—Skin disorder—Proguanil—malaria	0.00104	0.00597	CcSEcCtD
Ethosuximide—Agranulocytosis—Sulfadiazine—malaria	0.00104	0.00597	CcSEcCtD
Ethosuximide—Anorexia—Proguanil—malaria	0.00102	0.00586	CcSEcCtD
Ethosuximide—Hypersensitivity—Pyrimethamine—malaria	0.00101	0.00581	CcSEcCtD
Ethosuximide—Ataxia—Quinidine—malaria	0.000995	0.0057	CcSEcCtD
Ethosuximide—Ataxia—Quinine—malaria	0.000995	0.0057	CcSEcCtD
Ethosuximide—Abdominal pain upper—Clindamycin—malaria	0.000986	0.00565	CcSEcCtD
Ethosuximide—Lethargy—Quinidine barbiturate—malaria	0.000975	0.00559	CcSEcCtD
Ethosuximide—Cramp muscle—Clindamycin—malaria	0.000972	0.00557	CcSEcCtD
Ethosuximide—Abdominal pain upper—Quinine—malaria	0.000967	0.00554	CcSEcCtD
Ethosuximide—Abdominal pain upper—Quinidine—malaria	0.000967	0.00554	CcSEcCtD
Ethosuximide—CYP3A7-CYP3A51P—liver—malaria	0.000965	0.0488	CbGeAlD
Ethosuximide—Breast disorder—Quinidine—malaria	0.000957	0.00548	CcSEcCtD
Ethosuximide—Breast disorder—Quinine—malaria	0.000957	0.00548	CcSEcCtD
Ethosuximide—Erythema multiforme—Sulfadiazine—malaria	0.000948	0.00543	CcSEcCtD
Ethosuximide—Decreased appetite—Proguanil—malaria	0.000933	0.00534	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Proguanil—malaria	0.000926	0.00531	CcSEcCtD
Ethosuximide—Eosinophilia—Clindamycin—malaria	0.000923	0.00529	CcSEcCtD
Ethosuximide—Irritability—Quinidine barbiturate—malaria	0.000912	0.00522	CcSEcCtD
Ethosuximide—Ataxia—Quinidine barbiturate—malaria	0.000898	0.00515	CcSEcCtD
Ethosuximide—Abdominal discomfort—Clindamycin—malaria	0.000894	0.00512	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Proguanil—malaria	0.000877	0.00503	CcSEcCtD
Ethosuximide—Vomiting—Pyrimethamine—malaria	0.000876	0.00502	CcSEcCtD
Ethosuximide—Abdominal pain upper—Quinidine barbiturate—malaria	0.000873	0.005	CcSEcCtD
Ethosuximide—Pancytopenia—Quinidine—malaria	0.000869	0.00498	CcSEcCtD
Ethosuximide—Pancytopenia—Quinine—malaria	0.000869	0.00498	CcSEcCtD
Ethosuximide—Breast disorder—Quinidine barbiturate—malaria	0.000863	0.00495	CcSEcCtD
Ethosuximide—Abdominal pain—Proguanil—malaria	0.000848	0.00486	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Clindamycin—malaria	0.000824	0.00472	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Quinidine—malaria	0.000809	0.00463	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Quinine—malaria	0.000809	0.00463	CcSEcCtD
Ethosuximide—Abdominal discomfort—Pentoxifylline—malaria	0.00079	0.00453	CcSEcCtD
Ethosuximide—Pancytopenia—Quinidine barbiturate—malaria	0.000784	0.00449	CcSEcCtD
Ethosuximide—Pancytopenia—Pentoxifylline—malaria	0.000783	0.00448	CcSEcCtD
Ethosuximide—Leukopenia—Sulfadiazine—malaria	0.000781	0.00448	CcSEcCtD
Ethosuximide—Agranulocytosis—Clindamycin—malaria	0.000776	0.00445	CcSEcCtD
Ethosuximide—CYP3A5—hematopoietic system—malaria	0.000771	0.039	CbGeAlD
Ethosuximide—Agranulocytosis—Quinidine—malaria	0.000761	0.00436	CcSEcCtD
Ethosuximide—Agranulocytosis—Quinine—malaria	0.000761	0.00436	CcSEcCtD
Ethosuximide—Drowsiness—Quinidine barbiturate—malaria	0.000736	0.00422	CcSEcCtD
Ethosuximide—Drowsiness—Pentoxifylline—malaria	0.000735	0.00421	CcSEcCtD
Ethosuximide—Diarrhoea—Proguanil—malaria	0.000734	0.00421	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.00073	0.00418	CcSEcCtD
Ethosuximide—Urinary tract disorder—Quinidine—malaria	0.000723	0.00414	CcSEcCtD
Ethosuximide—Urinary tract disorder—Quinine—malaria	0.000723	0.00414	CcSEcCtD
Ethosuximide—CYP2E1—hematopoietic system—malaria	0.000719	0.0363	CbGeAlD
Ethosuximide—Urethral disorder—Quinine—malaria	0.000718	0.00411	CcSEcCtD
Ethosuximide—Urethral disorder—Quinidine—malaria	0.000718	0.00411	CcSEcCtD
Ethosuximide—Erythema multiforme—Clindamycin—malaria	0.000706	0.00404	CcSEcCtD
Ethosuximide—Erythema multiforme—Quinine—malaria	0.000692	0.00397	CcSEcCtD
Ethosuximide—Erythema multiforme—Quinidine—malaria	0.000692	0.00397	CcSEcCtD
Ethosuximide—Agranulocytosis—Quinidine barbiturate—malaria	0.000687	0.00394	CcSEcCtD
Ethosuximide—Eye disorder—Quinidine—malaria	0.000684	0.00392	CcSEcCtD
Ethosuximide—Eye disorder—Quinine—malaria	0.000684	0.00392	CcSEcCtD
Ethosuximide—Vomiting—Proguanil—malaria	0.000682	0.00391	CcSEcCtD
Ethosuximide—Anorexia—Sulfadiazine—malaria	0.000679	0.00389	CcSEcCtD
Ethosuximide—Rash—Proguanil—malaria	0.000677	0.00388	CcSEcCtD
Ethosuximide—Dermatitis—Proguanil—malaria	0.000676	0.00387	CcSEcCtD
Ethosuximide—Headache—Proguanil—malaria	0.000672	0.00385	CcSEcCtD
Ethosuximide—Immune system disorder—Quinidine—malaria	0.000661	0.00379	CcSEcCtD
Ethosuximide—Immune system disorder—Quinine—malaria	0.000661	0.00379	CcSEcCtD
Ethosuximide—Mediastinal disorder—Quinidine—malaria	0.00066	0.00378	CcSEcCtD
Ethosuximide—Mediastinal disorder—Quinine—malaria	0.00066	0.00378	CcSEcCtD
Ethosuximide—Urinary tract disorder—Quinidine barbiturate—malaria	0.000653	0.00374	CcSEcCtD
Ethosuximide—Urethral disorder—Quinidine barbiturate—malaria	0.000648	0.00371	CcSEcCtD
Ethosuximide—Mental disorder—Quinidine—malaria	0.000642	0.00368	CcSEcCtD
Ethosuximide—Mental disorder—Quinine—malaria	0.000642	0.00368	CcSEcCtD
Ethosuximide—Malnutrition—Quinidine—malaria	0.000637	0.00365	CcSEcCtD
Ethosuximide—Malnutrition—Quinine—malaria	0.000637	0.00365	CcSEcCtD
Ethosuximide—Nausea—Proguanil—malaria	0.000637	0.00365	CcSEcCtD
Ethosuximide—CYP3A5—kidney—malaria	0.000632	0.0319	CbGeAlD
Ethosuximide—Erythema multiforme—Quinidine barbiturate—malaria	0.000625	0.00358	CcSEcCtD
Ethosuximide—Muscle spasms—Clindamycin—malaria	0.000625	0.00358	CcSEcCtD
Ethosuximide—Decreased appetite—Sulfadiazine—malaria	0.000619	0.00355	CcSEcCtD
Ethosuximide—Eye disorder—Quinidine barbiturate—malaria	0.000618	0.00354	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000615	0.00352	CcSEcCtD
Ethosuximide—Immune system disorder—Quinidine barbiturate—malaria	0.000597	0.00342	CcSEcCtD
Ethosuximide—Immune system disorder—Pentoxifylline—malaria	0.000596	0.00341	CcSEcCtD
Ethosuximide—Mediastinal disorder—Quinidine barbiturate—malaria	0.000596	0.00341	CcSEcCtD
Ethosuximide—CYP2E1—kidney—malaria	0.000589	0.0298	CbGeAlD
Ethosuximide—Agitation—Quinidine—malaria	0.000586	0.00336	CcSEcCtD
Ethosuximide—Agitation—Quinine—malaria	0.000586	0.00336	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Sulfadiazine—malaria	0.000582	0.00334	CcSEcCtD
Ethosuximide—Leukopenia—Clindamycin—malaria	0.000582	0.00333	CcSEcCtD
Ethosuximide—Mental disorder—Quinidine barbiturate—malaria	0.000579	0.00332	CcSEcCtD
Ethosuximide—CYP3A4—hematopoietic system—malaria	0.000579	0.0292	CbGeAlD
Ethosuximide—Malnutrition—Quinidine barbiturate—malaria	0.000575	0.0033	CcSEcCtD
Ethosuximide—Leukopenia—Quinidine—malaria	0.000571	0.00327	CcSEcCtD
Ethosuximide—Leukopenia—Quinine—malaria	0.000571	0.00327	CcSEcCtD
Ethosuximide—Urticaria—Sulfadiazine—malaria	0.000566	0.00324	CcSEcCtD
Ethosuximide—Abdominal pain—Sulfadiazine—malaria	0.000563	0.00323	CcSEcCtD
Ethosuximide—Muscle spasms—Pentoxifylline—malaria	0.000552	0.00316	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000539	0.00309	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000539	0.00309	CcSEcCtD
Ethosuximide—CYP3A5—digestive system—malaria	0.000536	0.0271	CbGeAlD
Ethosuximide—Agitation—Quinidine barbiturate—malaria	0.000529	0.00303	CcSEcCtD
Ethosuximide—Agitation—Pentoxifylline—malaria	0.000528	0.00302	CcSEcCtD
Ethosuximide—Hypersensitivity—Sulfadiazine—malaria	0.000525	0.00301	CcSEcCtD
Ethosuximide—Leukopenia—Quinidine barbiturate—malaria	0.000515	0.00295	CcSEcCtD
Ethosuximide—Leukopenia—Pentoxifylline—malaria	0.000514	0.00295	CcSEcCtD
Ethosuximide—CYP3A5—blood—malaria	0.000511	0.0258	CbGeAlD
Ethosuximide—Nervous system disorder—Quinidine—malaria	0.00051	0.00292	CcSEcCtD
Ethosuximide—Nervous system disorder—Quinine—malaria	0.00051	0.00292	CcSEcCtD
Ethosuximide—Skin disorder—Quinidine—malaria	0.000505	0.0029	CcSEcCtD
Ethosuximide—Skin disorder—Quinine—malaria	0.000505	0.0029	CcSEcCtD
Ethosuximide—CYP2E1—digestive system—malaria	0.0005	0.0253	CbGeAlD
Ethosuximide—Anorexia—Quinidine—malaria	0.000496	0.00284	CcSEcCtD
Ethosuximide—Anorexia—Quinine—malaria	0.000496	0.00284	CcSEcCtD
Ethosuximide—Diarrhoea—Sulfadiazine—malaria	0.000487	0.00279	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000486	0.00279	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000486	0.00278	CcSEcCtD
Ethosuximide—CYP2E1—blood—malaria	0.000476	0.0241	CbGeAlD
Ethosuximide—CYP3A4—kidney—malaria	0.000474	0.024	CbGeAlD
Ethosuximide—Nervous system disorder—Quinidine barbiturate—malaria	0.00046	0.00264	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Clindamycin—malaria	0.000458	0.00262	CcSEcCtD
Ethosuximide—Fatigue—Clindamycin—malaria	0.000457	0.00262	CcSEcCtD
Ethosuximide—Skin disorder—Quinidine barbiturate—malaria	0.000456	0.00261	CcSEcCtD
Ethosuximide—Skin disorder—Pentoxifylline—malaria	0.000455	0.00261	CcSEcCtD
Ethosuximide—Vomiting—Sulfadiazine—malaria	0.000453	0.00259	CcSEcCtD
Ethosuximide—Decreased appetite—Quinine—malaria	0.000452	0.00259	CcSEcCtD
Ethosuximide—Decreased appetite—Quinidine—malaria	0.000452	0.00259	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Quinidine—malaria	0.000449	0.00257	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Quinine—malaria	0.000449	0.00257	CcSEcCtD
Ethosuximide—Rash—Sulfadiazine—malaria	0.000449	0.00257	CcSEcCtD
Ethosuximide—Dermatitis—Sulfadiazine—malaria	0.000449	0.00257	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dapsone—malaria	0.000448	0.00257	CcSEcCtD
Ethosuximide—Anorexia—Quinidine barbiturate—malaria	0.000448	0.00256	CcSEcCtD
Ethosuximide—Anorexia—Pentoxifylline—malaria	0.000447	0.00256	CcSEcCtD
Ethosuximide—Headache—Sulfadiazine—malaria	0.000446	0.00256	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Clindamycin—malaria	0.000434	0.00248	CcSEcCtD
Ethosuximide—Abdominal pain—Dapsone—malaria	0.000433	0.00248	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Quinine—malaria	0.000425	0.00244	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Quinidine—malaria	0.000425	0.00244	CcSEcCtD
Ethosuximide—Nausea—Sulfadiazine—malaria	0.000423	0.00242	CcSEcCtD
Ethosuximide—Urticaria—Clindamycin—malaria	0.000421	0.00241	CcSEcCtD
Ethosuximide—Abdominal pain—Clindamycin—malaria	0.000419	0.0024	CcSEcCtD
Ethosuximide—Somnolence—Quinidine barbiturate—malaria	0.000417	0.00239	CcSEcCtD
Ethosuximide—Somnolence—Pentoxifylline—malaria	0.000417	0.00239	CcSEcCtD
Ethosuximide—Urticaria—Quinidine—malaria	0.000413	0.00237	CcSEcCtD
Ethosuximide—Urticaria—Quinine—malaria	0.000413	0.00237	CcSEcCtD
Ethosuximide—Abdominal pain—Quinidine—malaria	0.000411	0.00236	CcSEcCtD
Ethosuximide—Abdominal pain—Quinine—malaria	0.000411	0.00236	CcSEcCtD
Ethosuximide—Decreased appetite—Quinidine barbiturate—malaria	0.000408	0.00234	CcSEcCtD
Ethosuximide—Decreased appetite—Pentoxifylline—malaria	0.000407	0.00233	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000405	0.00232	CcSEcCtD
Ethosuximide—CYP3A4—digestive system—malaria	0.000402	0.0203	CbGeAlD
Ethosuximide—CYP3A5—liver—malaria	0.000399	0.0202	CbGeAlD
Ethosuximide—Hypersensitivity—Clindamycin—malaria	0.000391	0.00224	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000384	0.0022	CcSEcCtD
Ethosuximide—Hypersensitivity—Quinidine—malaria	0.000383	0.0022	CcSEcCtD
Ethosuximide—Hypersensitivity—Quinine—malaria	0.000383	0.0022	CcSEcCtD
Ethosuximide—CYP3A4—blood—malaria	0.000383	0.0194	CbGeAlD
Ethosuximide—Gastrointestinal pain—Pentoxifylline—malaria	0.000383	0.0022	CcSEcCtD
Ethosuximide—Asthenia—Clindamycin—malaria	0.000381	0.00218	CcSEcCtD
Ethosuximide—Asthenia—Quinine—malaria	0.000373	0.00214	CcSEcCtD
Ethosuximide—Asthenia—Quinidine—malaria	0.000373	0.00214	CcSEcCtD
Ethosuximide—Urticaria—Quinidine barbiturate—malaria	0.000373	0.00214	CcSEcCtD
Ethosuximide—CYP2E1—liver—malaria	0.000373	0.0188	CbGeAlD
Ethosuximide—Urticaria—Pentoxifylline—malaria	0.000372	0.00213	CcSEcCtD
Ethosuximide—Abdominal pain—Quinidine barbiturate—malaria	0.000371	0.00213	CcSEcCtD
Ethosuximide—Abdominal pain—Pentoxifylline—malaria	0.000371	0.00212	CcSEcCtD
Ethosuximide—Diarrhoea—Clindamycin—malaria	0.000363	0.00208	CcSEcCtD
Ethosuximide—Diarrhoea—Quinine—malaria	0.000356	0.00204	CcSEcCtD
Ethosuximide—Diarrhoea—Quinidine—malaria	0.000356	0.00204	CcSEcCtD
Ethosuximide—Dizziness—Clindamycin—malaria	0.000351	0.00201	CcSEcCtD
Ethosuximide—Vomiting—Dapsone—malaria	0.000349	0.002	CcSEcCtD
Ethosuximide—Hypersensitivity—Quinidine barbiturate—malaria	0.000346	0.00198	CcSEcCtD
Ethosuximide—Hypersensitivity—Pentoxifylline—malaria	0.000345	0.00198	CcSEcCtD
Ethosuximide—Dizziness—Quinine—malaria	0.000344	0.00197	CcSEcCtD
Ethosuximide—Dizziness—Quinidine—malaria	0.000344	0.00197	CcSEcCtD
Ethosuximide—Headache—Dapsone—malaria	0.000343	0.00197	CcSEcCtD
Ethosuximide—Vomiting—Clindamycin—malaria	0.000337	0.00193	CcSEcCtD
Ethosuximide—Asthenia—Quinidine barbiturate—malaria	0.000337	0.00193	CcSEcCtD
Ethosuximide—Asthenia—Pentoxifylline—malaria	0.000336	0.00193	CcSEcCtD
Ethosuximide—Rash—Clindamycin—malaria	0.000334	0.00192	CcSEcCtD
Ethosuximide—Dermatitis—Clindamycin—malaria	0.000334	0.00191	CcSEcCtD
Ethosuximide—Headache—Clindamycin—malaria	0.000332	0.0019	CcSEcCtD
Ethosuximide—Vomiting—Quinine—malaria	0.000331	0.0019	CcSEcCtD
Ethosuximide—Vomiting—Quinidine—malaria	0.000331	0.0019	CcSEcCtD
Ethosuximide—Rash—Quinine—malaria	0.000328	0.00188	CcSEcCtD
Ethosuximide—Rash—Quinidine—malaria	0.000328	0.00188	CcSEcCtD
Ethosuximide—Dermatitis—Quinine—malaria	0.000328	0.00188	CcSEcCtD
Ethosuximide—Dermatitis—Quinidine—malaria	0.000328	0.00188	CcSEcCtD
Ethosuximide—Headache—Quinine—malaria	0.000326	0.00187	CcSEcCtD
Ethosuximide—Headache—Quinidine—malaria	0.000326	0.00187	CcSEcCtD
Ethosuximide—Nausea—Dapsone—malaria	0.000326	0.00187	CcSEcCtD
Ethosuximide—Diarrhoea—Quinidine barbiturate—malaria	0.000321	0.00184	CcSEcCtD
Ethosuximide—Diarrhoea—Pentoxifylline—malaria	0.000321	0.00184	CcSEcCtD
Ethosuximide—Nausea—Clindamycin—malaria	0.000315	0.0018	CcSEcCtD
Ethosuximide—Dizziness—Quinidine barbiturate—malaria	0.00031	0.00178	CcSEcCtD
Ethosuximide—Dizziness—Pentoxifylline—malaria	0.00031	0.00178	CcSEcCtD
Ethosuximide—Nausea—Quinidine—malaria	0.000309	0.00177	CcSEcCtD
Ethosuximide—Nausea—Quinine—malaria	0.000309	0.00177	CcSEcCtD
Ethosuximide—CYP3A4—liver—malaria	0.0003	0.0152	CbGeAlD
Ethosuximide—Vomiting—Quinidine barbiturate—malaria	0.000299	0.00171	CcSEcCtD
Ethosuximide—Vomiting—Pentoxifylline—malaria	0.000298	0.00171	CcSEcCtD
Ethosuximide—Rash—Quinidine barbiturate—malaria	0.000296	0.0017	CcSEcCtD
Ethosuximide—Dermatitis—Quinidine barbiturate—malaria	0.000296	0.00169	CcSEcCtD
Ethosuximide—CYP2E1—brain—malaria	0.000296	0.0149	CbGeAlD
Ethosuximide—Rash—Pentoxifylline—malaria	0.000296	0.00169	CcSEcCtD
Ethosuximide—Dermatitis—Pentoxifylline—malaria	0.000295	0.00169	CcSEcCtD
Ethosuximide—Headache—Quinidine barbiturate—malaria	0.000294	0.00169	CcSEcCtD
Ethosuximide—Headache—Pentoxifylline—malaria	0.000294	0.00168	CcSEcCtD
Ethosuximide—Nausea—Quinidine barbiturate—malaria	0.000279	0.0016	CcSEcCtD
Ethosuximide—Nausea—Pentoxifylline—malaria	0.000278	0.0016	CcSEcCtD
